About us

Our Vision

Making patients’ lives safer and more livable

Our Mission

We redefine drug delivery by replacing injections with oral formulations to increase patient compliance and provide save medication around the world

status quo

Currently we are funded by the FFG Spin-off Fellowship at TU Wien and we will found NovoArc GmbH in October 2021.

The NovoArc Team

We are a team of highly motivated scientists with entrepreneurial spirit.

Teamspirit is essential for NovoArc. Each and everyone of the team members has their own assets which are vital for our success. 

We are always looking for curious Researchers and offer Bachelor Theses and Master Theses.

If you want to be part of the Team contact us!

Dr. David
Wurm

future CEO

David Wurm is a process engineer and has a PhD in the field of biotechnology. For more than 5 years he is doing project management and is responsible for the communication with industrial partners, for the coordination of the team and for keeping deadlines.
Because of his trainings in the field of business development, management and law he will be CEO and co-founder of NovoArc GmbH.


Dr. Julian
Quehenberger

future CTO

In his PhD Thesis Dr. Julian Quehenberger investigated biotechnological applications of extremophilic microorganisms. In the last few years he was able to develop the underlying technology which is necessary to replace injection with pills. Globally he is probably the only person who can produce the necessary lipids at the needed quality and quantity. Because of his huge knowledge in this field and his spirit of innovation he will be CTO and co-founder of NovoArc GmbH.

Prof. Oliver
Spadiut

future CSO

Oliver Spadiut is Professor in Biotechnology and well known in this field. His scientific competence (>100 publications) and connections to the biotech industry (80% industry-oriented projects in cooperation with major pharmaceutical companies) allow him to give crucial scientific input.

He will be CSO and co-founder of NovoArc GmbH.


DI Kerstin
Rastädter

Upstream processing -
Lipid production

If there would be a title for “cultivation god”, Kerstin would definitely deserve it. Her knowledge about the fermentation process is the reasons why she is a key employee in the NovoArc Team. Her main focus is the optimization of the continuous cultivation process for the Archaea.

DI Viktor
Sedlmayr

Analytics &
Quality control

Viktor was already a high-performer during his Master Thesis, which he did under the supervision of Oliver Spadiut and David Wurm. During his studies he put a lot of focus on analytics and became an expert in lipid and liposome analytics as well as Archaeosome formulation.

Christina
Horn, BSc.

Downstream processing -
Liposome Formulation

Christina joined the team in September 2020. She is currently working on her masters degree at the Technical University of Graz. Her main focus is the formulation of Archaeosomes with different active pharmaceutical ingredients.

Matthias
Pichler, BSc.

Downstream processing -
Lipid purifiication

Matthias is part of the NovoArc Team since February 2020. He started as intern during his studies of Biotechnology and Bioengineering. He has gathered a lot of expertise in lipid extraction and loves implementing innovative technologies.

Introducing our Advisors

All new projects face challenges. It's highly important to have committed and experienced advisors.

We are currently expanding our advisory board. Feel free to contact us if you want to support our mission.

Klara Brandstätter

CEO at I.E.C.T. Hermann Hauser Managment GmbH

Dr. Sylvia Nanz

Medical Director at Pfizer

Supported by